Fujifilm has opened a new factory in Oita Prefecture to triple post-CMP cleaner output, capitalizing on AI data center demand.
The company spent ¥7 billion ($44 million) on the expansion and now sees semiconductors as its most promising growth driver.
It is weighing a spinoff of its struggling office equipment unit to focus capital on chip materials and drugs.
What happened
Fujifilm opened a new fabrication building this month in Oita Prefecture that will triple its production of post-CMP cleaners—materials that remove particles from semiconductor wafers after chemical-mechanical polishing. The company invested ¥7 billion ($44 million) in the expansion.
Why it matters
Data center buildouts for AI have created supply bottlenecks across chip manufacturing. Semiconductors are now Fujifilm's most promising growth segment as its traditional office equipment business stagnates; revenue from semiconductor materials grew 25% year-over-year in the April-June quarter.
What to watch
Fujifilm is considering spinning off its legacy office equipment business—which still accounts for 35% of group revenue—as a separate company to speed investment in semiconductor materials and biopharmaceuticals. The company has also developed AI-driven tools that compress chemical formula research from years into months.
Ask the AI about this article →
Fujifilm's pivot from cameras and copiers to semiconductor materials reflects a structural opportunity created by AI infrastructure expansion. Data center buildouts have strained chip supply chains, forcing manufacturers to secure stable supplies of specialized chemicals. Fujifilm's ¥7 billion investment signals confidence that this demand will sustain—the company forecasts the market for these materials will grow rapidly. The 25% year-over-year revenue growth in semiconductors in the April-June quarter underscores how decisively AI buildout has shifted Fujifilm's business mix.
The company's consideration of a spinoff for office equipment is a direct acknowledgement that legacy business constraints—the unit still absorbs capital and management attention despite accounting for only 35% of revenue—now impede the growth strategy. By separating office equipment, Fujifilm aims to make investment decisions faster in semiconductors and biopharmaceuticals. The AI-driven chemical discovery tools the company has developed are a differentiator: by compressing research timelines from years to months, Fujifilm can respond more quickly to chipmakers' evolving material needs across lithography, polishing, and advanced packaging.
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytime
Ask AI anything about this article. Q&As are published on this page for other readers too.
